JP2001518118A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001518118A5 JP2001518118A5 JP1998545973A JP54597398A JP2001518118A5 JP 2001518118 A5 JP2001518118 A5 JP 2001518118A5 JP 1998545973 A JP1998545973 A JP 1998545973A JP 54597398 A JP54597398 A JP 54597398A JP 2001518118 A5 JP2001518118 A5 JP 2001518118A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4146197P | 1997-03-25 | 1997-03-25 | |
| US60/041,461 | 1997-03-25 | ||
| PCT/US1998/005922 WO1998042353A1 (en) | 1997-03-25 | 1998-03-24 | Modulation of human mast cell activation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001518118A JP2001518118A (ja) | 2001-10-09 |
| JP2001518118A5 true JP2001518118A5 (enExample) | 2005-11-24 |
Family
ID=21916643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54597398A Ceased JP2001518118A (ja) | 1997-03-25 | 1998-03-24 | ヒト肥満細胞活性化のモジュレーション |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6372724B1 (enExample) |
| EP (1) | EP1011686B9 (enExample) |
| JP (1) | JP2001518118A (enExample) |
| AT (1) | ATE470441T1 (enExample) |
| AU (1) | AU741713B2 (enExample) |
| CA (1) | CA2288821C (enExample) |
| DE (1) | DE69841711D1 (enExample) |
| DK (1) | DK1011686T3 (enExample) |
| WO (1) | WO1998042353A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2288821C (en) * | 1997-03-25 | 2008-10-14 | Allegheny University Of The Health Sciences | Modulation of human mast cell activation |
| AU770975B2 (en) * | 1999-06-18 | 2004-03-11 | Alcon Laboratories, Inc. | Topical ophthalmic mast cell stabilizers for treating allergic eye diseases |
| GB9916757D0 (en) | 1999-07-17 | 1999-09-15 | Glaxo Group Ltd | Method |
| WO2001071342A2 (en) * | 2000-03-23 | 2001-09-27 | Novartis Ag | Identification of mast cell/basophil activation inhibitors |
| US20040077654A1 (en) * | 2001-01-15 | 2004-04-22 | Bouillot Anne Marie Jeanne | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| US20040072865A1 (en) * | 2001-01-15 | 2004-04-15 | Bouillot Anne Marie Jeanne | Aryl piperidine derivatives as inducers of ldl-receptor expression |
| EP1351937A1 (en) * | 2001-01-15 | 2003-10-15 | Glaxo Group Limited | Aryl piperidine derivatives as inducers of ldl-receptor expression |
| JP2005532254A (ja) * | 2001-11-06 | 2005-10-27 | インスパイアー ファーマシューティカルズ，インコーポレイティド | 炎症性疾患を治療又は予防する方法 |
| WO2003070902A2 (en) * | 2002-02-20 | 2003-08-28 | Incyte Corporation | Receptors and membrane-associated proteins |
| US20070276126A1 (en) * | 2002-08-13 | 2007-11-29 | Incyte Corporation | Cell adhesion and extracellular matrix proteins |
| US20070219353A1 (en) * | 2002-09-03 | 2007-09-20 | Incyte Corporation | Immune Response Associated Proteins |
| WO2004033636A2 (en) * | 2002-10-04 | 2004-04-22 | Incyte Corporation | Protein modification and maintenance molecules |
| US20070009886A1 (en) * | 2002-11-12 | 2007-01-11 | Incyte Corporation | Carbohydrate-associated proteins |
| WO2004044165A2 (en) * | 2002-11-13 | 2004-05-27 | Incyte Corporation | Lipid-associated proteins |
| WO2004048550A2 (en) * | 2002-11-26 | 2004-06-10 | Incyte Corporation | Immune response associated proteins |
| WO2004098539A2 (en) | 2003-04-30 | 2004-11-18 | Incyte Corporation | Kinases and phosphatases |
| JP2008507368A (ja) * | 2004-07-22 | 2008-03-13 | デュスカ サイエンティフィック カンパニー | 肺疾患を診断、モニタリングおよび治療するための方法 |
| DK2407484T3 (en) | 2005-06-24 | 2016-09-05 | The Walter And Eliza Hall Inst Of Medical Res | Therapeutic pro-apoptotic BH3-like molecules, and methods of generating and / or selecting those |
| GB0601058D0 (en) * | 2006-01-19 | 2006-03-01 | Univ Southampton | Mast Cell Carboxypeptidase As A Marker For Anaphylaxis And Mastocytosis |
| CA2680801A1 (en) * | 2007-03-14 | 2008-09-18 | Sierra Molecular Corporation | Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule |
| US10517839B2 (en) * | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
| US10107795B2 (en) | 2012-10-25 | 2018-10-23 | The United States Of America As Represented By The Department Of Veterans Affairs | Composition and methods for the prevention and treatment of diet-induced obesity |
| US10614684B2 (en) | 2017-01-31 | 2020-04-07 | The United States Government As Represented By The | Treatment of kidney diseases associated with elevated AVP |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53148539A (en) * | 1977-05-30 | 1978-12-25 | Fujisawa Pharmaceut Co Ltd | Antiallergic agnet |
| US5158940A (en) * | 1990-02-14 | 1992-10-27 | The United States Government As Represented By The Secretary, Dhhs | Use of suramin to treat rheumatologic diseases |
| US5504090A (en) * | 1994-03-30 | 1996-04-02 | Trustees Of The University Of Pennsylvania | Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury |
| US5985603A (en) * | 1994-05-27 | 1999-11-16 | Glaxo Group Limited | P2x receptor DNA and protein sequence |
| US5733916A (en) | 1995-03-24 | 1998-03-31 | The Trustees Of The University Of Pennsylvania | Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
| US5874420A (en) | 1995-12-26 | 1999-02-23 | Allegheny University Of The Health Sciences | Process for regulating vagal tone |
| CA2288821C (en) * | 1997-03-25 | 2008-10-14 | Allegheny University Of The Health Sciences | Modulation of human mast cell activation |
-
1998
- 1998-03-24 CA CA002288821A patent/CA2288821C/en not_active Expired - Fee Related
- 1998-03-24 JP JP54597398A patent/JP2001518118A/ja not_active Ceased
- 1998-03-24 EP EP98917959A patent/EP1011686B9/en not_active Expired - Lifetime
- 1998-03-24 US US09/381,692 patent/US6372724B1/en not_active Expired - Fee Related
- 1998-03-24 AU AU70985/98A patent/AU741713B2/en not_active Ceased
- 1998-03-24 DK DK98917959.3T patent/DK1011686T3/da active
- 1998-03-24 DE DE69841711T patent/DE69841711D1/de not_active Expired - Lifetime
- 1998-03-24 WO PCT/US1998/005922 patent/WO1998042353A1/en not_active Ceased
- 1998-03-24 AT AT98917959T patent/ATE470441T1/de active
-
2001
- 2001-12-20 US US10/027,052 patent/US6465441B2/en not_active Expired - Fee Related